Proton Pump Inhibitors Accelerate Endothelial Senescence

133Citations
Citations of this article
120Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Rationale: Proton pump inhibitors (PPIs) are popular drugs for gastroesophageal reflux, which are now available for long-term use without medical supervision. Recent reports suggest that PPI use is associated with cardiovascular, renal, and neurological morbidity. Objective: To study the long-term effect of PPIs on endothelial dysfunction and senescence and investigate the mechanism involved in PPI-induced vascular dysfunction. Methods and Results: Chronic exposure to PPIs impaired endothelial function and accelerated human endothelial senescence by reducing telomere length. Conclusions: Our data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality.

Cite

CITATION STYLE

APA

Yepuri, G., Sukhovershin, R., Nazari-Shafti, T. Z., Petrascheck, M., Ghebre, Y. T., & Cooke, J. P. (2016). Proton Pump Inhibitors Accelerate Endothelial Senescence. Circulation Research, 118(12), e36–e42. https://doi.org/10.1161/CIRCRESAHA.116.308807

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free